Article Details

Raludotatug Deruxtecan Promising in Platinum-Resistant Advanced Ovarian Cancer

Retrieved on: 2024-03-17 20:02:10

Tags for this article:

Click the tags to see associated articles and topics

Raludotatug Deruxtecan Promising in Platinum-Resistant Advanced Ovarian Cancer. View article details on hiswai:

Excerpt

Aghajanian disclosed relationships with Artios Pharma, AstraZeneca, Merck, NRG Oncology, and the GOG Foundation. Primary Source. Society of ...

Article found on: www.medpagetoday.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up